Accrued research and development software.

No definition available.

Name:	celu_AccruedResearchAndDevelopmentSoftware
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Annual maintenance fee.

+ References

No definition available.

+ Details

Name:	celu_AnnualMaintenanceFee
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Clinical and regulatory milestones.

+ References

No definition available.

+ Details

Name:	celu_ClinicalAndRegulatoryMilestones
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Commitments and contingencies (Details) [Line Items]

+ References

No definition available.

+ Details

Name:	celu_CommitmentsAndContingenciesDetailsLineItems
Namespace Prefix:	celu_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

License agreement notice period.

+ References

No definition available.

+ Details

Name:	celu_LicenseAgreementNoticePeriod
Namespace Prefix:	celu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Payment subscription period.

+ References

No definition available.

+ Details

Name:	celu_PaymentSubscriptionPeriod
Namespace Prefix:	celu_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Payments for master subscription agreement.

+ References

No definition available.

+ Details

Name:	celu_PaymentsForMasterSubscriptionAgreement
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Sale of biomaterial products amount.

+ References

No definition available.

+ Details

Name:	celu_SaleOfBiomaterialProductsAmount
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Upfront fee.

+ References

No definition available.

+ Details

Name:	celu_UpfrontFee
Namespace Prefix:	celu_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479668/805-30-25-6

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 35
-Paragraph 1
-Subparagraph (b)
-SubTopic 30
-Topic 805
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479613/805-30-35-1

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

+ Details

Name:	us-gaap_BusinessExitCosts1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Costs of sales and operating expenses for the period incurred from transactions with related parties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_CostsAndExpensesRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_LongtermPurchaseCommitmentPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=celu_EvolutionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=celu_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=celu_PalantirTechnologiesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=celu_MasterSubscriptionAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=celu_SoftwareCeaseUseCostsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=celu_LegacyCelularitysMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=celu_HLICellularTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionAxis=celu_LLCAndAnthrogenesisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands			1 Months Ended	6 Months Ended
	Apr. 17, 2023	May 05, 2021	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Commitments And Contingencies Details [Line Items]
Contingent consideration				$ 1,606		$ 105,945
Accrued R&D software				24,000		7,333
Evolution
Commitments And Contingencies Details [Line Items]
Sale of biomaterial products amount	$ 2,350
Sirion License
Commitments And Contingencies Details [Line Items]
Upfront fee			$ 136
Annual maintenance fee			113
Clinical and regulatory milestones			$ 5,099
License agreement period			10 years
Notice period			30 days
Palantir Technologies, Inc \| Master Subscription Agreement
Commitments And Contingencies Details [Line Items]
Payments for master subscription agreement		$ 40,000
Payment subscription period		5 years
Costs related to straight line basis agreement					$ 4,000
Accrued R&D software				31,250		7,333
Palantir Technologies, Inc \| Software cease-use Costs
Commitments And Contingencies Details [Line Items]
Exit or disposal costs				23,918
Legacy Celularity \| HLI Cellular Therapeutics, LLC \| Anthrogenesis
Commitments And Contingencies Details [Line Items]
Contingent consideration				$ 1,606		$ 105,945